The human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseases

Current Genomics

Volumn 11, Issue 4, 2010, Pages 238-245

  Zhu, Hu ^a   Lo, Hui Wen ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Cancer; CD24; GLI1; GLI1 N; Polymorphism; Smoothened; Sonic hedgehog pathway; Splice variants; tGLI1

Indexed keywords

SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER INVASION; DNA POLYMORPHISM; DRUG SENSITIVITY; ENTERITIS; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; HUMAN; PROTEIN STRUCTURE; TUMOR GROWTH; WILD TYPE;

ERINACEIDAE;

EID: 77953661272     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210791233108     Document Type: Article

References (78)

1. Kinzler, K. W.; Bigner, S. H.; Bigner, D. D.; Trent, J. M.; Law, M. L.; O'Brien, S. J.; Wong, A. J.; Vogelstein, B. Identification of an amplified, highly expressed gene in a human glioma. Science (New York, N.Y), 1987, 236, 70-73.
2. Kinzler, K. W.; Ruppert, J. M.; Bigner, S. H.; Vogelstein, B. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature, 1988, 332, 371-374.
3. Kinzler, K. W.; Vogelstein, B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol. Cell. Biol., 1990, 10, 634-642.
4. Dahmane, N.; Sanchez, P.; Gitton, Y.; Palma, V.; Sun, T.; Beyna, M.; Weiner, H.; Ruiz i Altaba, A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development (Cambridge, England), 2001, 128, 5201-5212.
5. Echelard, Y.; Epstein, D. J.; St-Jacques, B.; Shen, L.; Mohler, J.; McMahon, J. A.; McMahon, A. P. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell, 1993, 75, 1417-1430.
6. Roelink, H.; Augsburger, A.; Heemskerk, J.; Korzh, V.; Norlin, S.; Ruiz i Altaba, A.; Tanabe, Y.; Placzek, M.; Edlund, T.; Jessell, T. M. et al. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell, 1994, 76, 761-775.
7. Dahmane, N.; Ruizi Altaba, A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development (Cambridge, England), 1999, 126, 3089-3100.
8. Clement, V.; Sanchez, P.; de Tribolet, N.; Radovanovic, I.; Ruiz I Altaba, A. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity. Curr. Biol., 2007, 17, 165-172.
9. Kasper, M.; Regl, G.; Frischauf, A. M.; Aberger, F. GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur. J. Cancer, 2006, 42, 437-445.
10. Xie, J. Hedgehog signaling pathway: development of antagonists for cancer therapy. Curr. Oncol. Rep., 2008, 10, 107-113.
11. Gordon, A. T.; Brinkschmidt, C.; Anderson, J.; Coleman, N.; Dockhorn-Dworniczak, B.; Pritchard-Jones, K.; Shipley, J. A novel and consistent amplicon at 13q31 associated with alveolar rhabdo-myosarcoma. Genes, Chromosomes Cancer, 2000, 28, 220-226.
12. Lees, C. W.; Zacharias, W. J.; Tremelling, M.; Noble, C. L.; Nimmo, E. R.; Tenesa, A.; Cornelius, J.; Torkvist, L.; Kao, J.; Far-rington, S.; Drummond, H. E.; Ho, G. T.; Arnott, I. D.; Appelman, H. D.; Diehl, L.; Campbell, H.; Dunlop, M. G.; Parkes, M.; Howie, S. E.; Gumucio, D. L.; Satsangi, J. Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways. PLoS Medicine, 2008, 5, e239.
13. Shimokawa, T.; Tostar, U.; Lauth, M.; Palaniswamy, R.; Kasper, M.; Toftgard, R.; Zaphiropoulos, P. G. Novel human glioma-associated oncogene 1 (GLI1) splice variants reveal distinct mechanisms in the terminal transduction of the hedgehog signal. J. Biol. Chem., 2008, 283, 14345-14354.
14. Lo, H. W.; Zhu, H.; Cao, X.; Aldrich, A.; Ali-Osman, F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res., 2009, 69, 6790-6798.
15. Wang, X. Q.; Rothnagel, J. A. Post-transcriptional regulation of the gli1 oncogene by the expression of alternative 5' untranslated regions. J. Biol. Chem., 2001, 276, 1311-1316.
16. Dahlen, A.; Fletcher, C. D.; Mertens, F.; Fletcher, J. A.; Perez-Atayde, A. R.; Hicks, M. J.; Debiec-Rychter, M.; Sciot, R.; Wejde, J.; Wedin, R.; Mandahl, N.; Panagopoulos, I. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am. J. Pathol., 2004, 164, 1645-1653.
17. Dahlen, A.; Mertens, F.; Mandahl, N.; Panagopoulos, I. Molecular genetic characterization of the genomic ACTB-GLI fusion in peri-cytoma with t(7;12). Biochem. Biophys. Res. Commun., 2004, 325, 1318-1323.
18. Arheden, K.; Ronne, M.; Mandahl, N.; Heim, S.; Kinzler, K. W.; Vogelstein, B.; Mitelman, F. In situ hybridization localizes the human putative oncogene GLI to chromosome subbands 12q13.3-14.1. Hum. Genet., 1989, 82, 1-2.
19. Bigner, S. H.; Wong, A. J.; Mark, J.; Muhlbaier, L. H.; Kinzler, K. W.; Vogelstein, B.; Bigner, D. D. Relationship between gene amplification and chromosomal deviations in malignant human glio-mas. Cancer Genet. Cytogenet., 1987, 29, 165-170.
20. Wong, A. J.; Bigner, S. H.; Bigner, D. D.; Kinzler, K. W.; Hamilton, S. R.; Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. U.S.A., 1987, 84, 6899-6903.
21. Forus, A.; Florenes, V. A.; Maelandsmo, G. M.; Meltzer, P. S.; Fodstad, O.; Myklebost, O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some am-plica do not include MDM2. Cell Growth Differ., 1993, 4, 1065-1070.
22. Rao, S. K.; Edwards, J.; Joshi, A. D.; Siu, I. M.; Riggins, G. J. A survey of glioblastoma genomic amplifications and deletions. J. Neurooncol., 2010, 96, 169-79.
23. Bigner, S. H.; Friedman, H. S.; Vogelstein, B.; Oakes, W. J.; Bigner, D. D. Amplification of the c-myc gene in human medul-loblastoma cell lines and xenografts. Cancer Res., 1990, 50, 2347-2350.
24. Wasson, J. C.; Saylors, R. L., 3rd; Zeltzer, P.; Friedman, H. S.; Bigner, S. H.; Burger, P. C.; Bigner, D. D.; Look, A. T.; Douglass, E. C.; Brodeur, G. M. Oncogene amplification in pediatric brain tumors. Cancer Res., 1990, 50, 2987-2990.
25. Roberts, W. M.; Douglass, E. C.; Peiper, S. C.; Houghton, P. J.; Look, A. T. Amplification of the gli gene in childhood sarcomas. Cancer Res., 1989, 49, 5407-5413.
26. Stein, U.; Eder, C.; Karsten, U.; Haensch, W.; Walther, W.; Schlag, P. M. GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. Cancer Res., 1999, 59, 1890-1895.
27. Arheden, K.; Nilbert, M.; Heim, S.; Mandahl, N.; Mitelman, F. Noamplification or rearrangement of INT1, GLI, or COL2A1 in uterine leiomyomas with t(12;14)(q14-15;q23-24). Cancer Genet. Cytogenet., 1989, 39, 195-201.
28. Tornillo, L.; Duchini, G.; Carafa, V.; Lugli, A.; Dirnhofer, S.; Di Vizio, D.; Boscaino, A.; Russo, R.; Tapia, C.; Schneider-Stock, R.; Sauter, G.; Insabato, L.; Terracciano, L.M. Patterns of gene amplification in gastrointestinal stromal tumors (GIST). Lab. Invest., 2005, 85, 921-931.
29. Simon, R.; Struckmann, K.; Schraml, P.; Wagner, U.; Forster, T.; Moch, H.; Fijan, A.; Bruderer, J.; Wilber, K.; Mihatsch, M. J.; Gas-ser, T.; Sauter, G. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene, 2002, 21, 2476-2483.
30. Kinzler, K. W.; Vogelstein, B. EcoRI polymorphism within the GLI gene (chromosome 12q13.3-14.1). Nucleic Acids Res., 1990, 18, 2834.
31. Hynes, M.; Stone, D. M.; Dowd, M.; Pitts-Meek, S.; Goddard, A.; Gurney, A.; Rosenthal, A. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron, 19, 15-26.
32. Kogerman, P.; Grimm, T.; Kogerman, L.; Krause, D.; Unden, A. B.; Sandstedt, B.; Toftgard, R.; Zaphiropoulos, P. G. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat. Cell Biol., 1999, 1, 312-319.
33. Wang, X. Q.; Chan, N.; Rothnagel, J. A. Letters to the editor: identification of polymorphic variants of the GLI1 oncogene. J. Invest. Dermatol., 2000, 115, 328-329.
34. Yoon, J. W.; Liu, C. Z.; Yang, J. T.; Swart, R.; Iannaccone, P.; Walterhouse, D. GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain. J. Biol. Chem., 273, 3496-3501.
35. Raffel, C.; Jenkins, R. B.; Frederick, L.; Hebrink, D.; Alderete, B.; Fults, D. W.; James, C. D. Sporadic medulloblastomas contain PTCH mutations. Cancer Res., 1997, 57, 842-845.
36. Sun, L.S.; Li, X.F.; Li, T.J. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J. Dent. Res., 2008, 87, 575-579.
37. Bailey, E.C.; Milenkovic, L.; Scott, M.P.; Collawn, J.F.; Johnson, R.L. Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts. J. Biol. Chem., 2002, 277, 33632-33640.
38. Takahashi, C.; Kanazawa, N.; Yoshikawa, Y.; Yoshikawa, R.; Saitoh, Y.; Chiyo, H.; Tanizawa, T.; Hashimoto-Tamaoki, T.; Na-kano, Y. Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients. J. Hum. Genet., 2009, 54, 403-408.
39. Lindstrom, E.; Shimokawa, T.; Toftgard, R.; Zaphiropoulos, P.G. PTCH mutations: distribution and analyses. Hum. Mutat., 2006, 27, 215-219.
40. Reifenberger, J.; Wolter, M.; Weber, R. G.; Megahed, M.; Ruzicka, T.; Lichter, P.; Reifenberger, G. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroecto-dermal tumors of the central nervous system. Cancer Res., 1998, 58, 1798-1803.
41. Xie, J.; Murone, M.; Luoh, S. M.; Ryan, A.; Gu, Q.; Zhang, C.; Bonifas, J. M.; Lam, C. W.; Hynes, M.; Goddard, A.; Rosenthal, A.; Epstein, E. H.; Jr. de Sauvage, F. J. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature, 1998, 391, 90-92.
42. Yauch, R. L.; Dijkgraaf, G. J.; Alicke, B.; Januario, T.; Ahn, C. P.; Holcomb, T.; Pujara, K.; Stinson, J.; Callahan, C. A.; Tang, T.; Ba-zan, J. F.; Kan, Z.; Seshagiri, S.; Hann, C. L.; Gould, S. E.; Low, J. A.; Rudin, C. M.; de Sauvage, F. J. Smoothened mutation confers resistance to Hedgehog pathway inhibitor in medulloblastoma. Science (New York, N.Y), 2009, 326, 572-574.
43. Lam, C. W.; Xie, J.; To, K. F.; Ng, H. K.; Lee, K. C.; Yuen, N. W.; Lim, P. L.; Chan, L. Y.; Tong, S. F.; McCormick, F. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene, 1999, 18, 833-836.
44. Roessler, E.; Du, Y. Z.; Mullor, J. L.; Casas, E.; Allen, W. P.; Gillessen-Kaesbach, G.; Roeder, E. R.; Ming, J. E.; Ruiz, i.; Altaba, A.; Muenke, M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosen-cephaly-like features. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 13424-13429.
45. Shin, S. H.; Kogerman, P.; Lindstrom, E.; Toftgard, R.; Biesecker, L. G. GLI3 mutations in human disorders mimic Drosophila cubi-tus interruptus protein functions and localization. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 2880-2884.
46. Kang, S.; Graham, J. M., Jr.; Olney, A. H.; Biesecker, L. G. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet., 1997, 15, 266-268.
47. Radhakrishna, U.; Wild, A.; Grzeschik, K. H.; Antonarakis, S. E. Mutation in GLI3 in postaxial polydactyly type A. Nat. Genet., 1997, 17, 269-271.
48. Roessler, E.; Ermilov, A. N.; Grange, D. K.; Wang, A.; Grachtchouk, M.; Dlugosz, A. A.; Muenke, M. A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum. Mol. Genet., 2005, 14, 2181-2188.
49. Tanimura, A.; Dan, S.; Yoshida, M. Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome. J. Virol., 1998, 72, 3958-3964.
50. Huntzicker, E. G.; Estay, I. S.; Zhen, H.; Lokteva, L. A.; Jackson, P. K.; Oro, A. E. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev., 2006, 20, 276-281.
51. Dunaeva, M.; Michelson, P.; Kogerman, P.; Toftgard, R. Characterization of the physical interaction of Gli proteins with SUFU proteins. J. Biol. Chem., 2003, 278, 5116-5122.
52. Baumann, P.; Cremers, N.; Kroese, F.; Orend, G.; Chiquet-Ehrismann, R.; Uede, T.; Yagita, H.; Sleeman, J. P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res., 2005, 65, 10783-10793.
53. Runz, S.; Mierke, C. T.; Joumaa, S.; Behrens, J.; Fabry, B.; Al-tevogt, P. CD24 induces localization of beta1 integrin to lipid raft domains. Biochem. Biophys. Res. Commun., 2008, 365, 35-41.
54. Rao, J. S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev., 2003, 3, 489-501.
55. James, C.D.; Cavenee, W.K. Stem Cells for Treating Glioblastoma: How Close to Reality? Neuro Oncol., 2009, 11, 101.
56. Li, G.; Wong, A. J. EGF receptor variant III as a target antigen for tumor immunotherapy. Expert Rev. Vaccines, 2008, 7, 977-985.
57. Lo, H.-W. EGFR-targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance. Curr. Mol. Pharmacol., 2010, 3, 37-52.
58. Katoh, Y.; Katoh, M. Hedgehog target genes: mechanisms of car-cinogenesis induced by aberrant hedgehog signaling activation. Curr. Mol. Med., 2009, 9, 873-886.
59. Agren, M.; Kogerman, P.; Kleman, M. I.; Wessling, M.; Toftgard, R. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene, 2004, 330, 101-114.
60. Sasaki, H.; Hui, C.; Nakafuku, M.; Kondoh, H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development (Cambridge, England), 1997, 124, 1313-1322.
61. Teh, M. T.; Wong, S. T.; Neill, G. W.; Ghali, L. R.; Philpott, M. P.; Quinn, A. G. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res., 2002, 62, 4773-4780.
62. Laner-Plamberger, S.; Kaser, A.; Paulischta, M.; Hauser-Kronberger, C.; Eichberger, T.; Frischauf, A. M. Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene, 2009, 28, 1639-1651.
63. Yoon, J. W.; Kita, Y.; Frank, D. J.; Majewski, R. R.; Konicek, B. A.; Nobrega, M. A.; Jacob, H.; Walterhouse, D.; Iannaccone, P. Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell Transformation. J. Biol. Chem., 2002, 277, 5548-5555.
64. Duman-Scheel, M.; Weng, L.; Xin, S.; Du, W. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature, 2002, 417, 299-304.
65. Bach, L. A. IGFBP-6 five years on; not so 'forgotten'? Growth Horm. IGF Res., 2005, 15, 185-192.
66. Louro, I. D.; Bailey, E. C.; Li, X.; South, L. S.; McKie-Bell, P. R.; Yoder, B. K.; Huang, C. C.; Johnson, M. R.; Hill, A. E.; Johnson, R. L.; Ruppert, J. M. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res., 2002, 62, 5867-5873.
67. Li, X.; Deng, W.; Nail, C. D.; Bailey, S. K.; Kraus, M. H.; Ruppert, J. M.; Lobo-Ruppert, S. M. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene, 2006, 25, 609-621.
68. Lo, H. W.; Hsu, S. C.; Xia, W.; Cao, X.; Shih, J. Y.; Wei, Y.; Ab-bruzzese, J. L.; Hortobagyi, G. N.; Hung, M. C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res., 2007, 67, 9066-9076.
69. Yoon, J. W.; Gilbertson, R.; Iannaccone, S.; Iannaccone, P.; Wal-terhouse, D. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. Int. J. Cancer, 2009, 124, 109-119.
70. Das, S.; Harris, L. G.; Metge, B. J.; Liu, S.; Riker, A. I.; Samant, R. S.; Shevde, L. A. The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J. Biol. Chem., 2009, 284, 22888-22897.
71. Buback, F.; Renkl, A. C.; Schulz, G.; Weiss, J. M. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp. Dermatol., 2009, 18, 750-759.
72. Bigelow, R. L.; Chari, N. S.; Unden, A. B.; Spurgers, K. B.; Lee, S.; Roop, D. R.; Toftgard, R.; McDonnell, T. J. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J. Biol. Chem., 2004, 279, 1197-1205.
73. Datta, K.; Shah, P.; Srivastava, T.; Mathur, S. G.; Chattopadhyay P.; Sinha, S. Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides. Cancer Gene Ther., 2004, 11, 525-531.
74. Lo, H. W.; Stephenson, L.; Cao, X.; Milas, M.; Pollock, R.; Ali-Osman, F. Identification and Functional Characterization of the Human Glutathione S-Transferase P1 Gene as a Novel Transcrip-tional Target of the p53 Tumor Suppressor Gene. Mol. Cancer Res., 2008, 6, 843-850.
75. Chang, F. L.; Ling, Y. F.; Lai, M. D. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells. Anticancer Res., 2000, 20, 329-336.
76. Fan, S.; Smith, M. L.; Rivet, D. J., 2nd; Duba, D.; Zhan, Q.; Kohn, K. W.; Fornace, A. J., Jr. O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxi-fylline. Cancer Res., 1995, 55, 1649-1654.
77. Yazlovitskaya, E. M.; DeHaan, R. D.; Persons, D. L. Prolonged Wild-Type p53 Protein Accumulation and Cisplatin Resistance. Biochem. Biophys. Res. Commun., 2001, 283, 732-737.
78. Sharma, S.; Salehi, F.; Scheithauer, B. W.; Rotondo, F.; Syro, L. V.; Kovacs, K. Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis. Anticancer Res., 2009, 29, 3759-3768.